Judith L. Swain

Insider Reports History

Location
The Woodlands, TX
Signature
/s/ Judith L. Swain
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Judith L. Swain:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. Director Restricted Stock Units 89,312 $96,442 $2.62 03 Jun 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Common Stock 85,174 $43,438 $0.5100 13 May 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 103,806 03 Jun 2025 Direct
Prometheus Biosciences, Inc. Director Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Director Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Judith L. Swain

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 03 Jun 2025 2 $0 4 Director 03 Jun 2025, 16:25
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2025 2 $0 4 Director 13 May 2025, 17:52
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2024 2 $0 4 Director 13 May 2024, 16:05
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2024 2 $0 4 Director 29 Apr 2024, 16:21
/report/000089924323015756-swain-judith-l-2023-06-16 Prometheus Biosciences, Inc. 16 Jun 2023 3 $0 4 Director 16 Jun 2023, 16:00
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2023 2 $0 4 Director 22 May 2023, 16:07
/report/000120919123031191-swain-judith-l-2023-05-19 Prometheus Biosciences, Inc. 19 May 2023 1 $0 4 Director 19 May 2023, 17:45
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:30
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2022 2 $0 4 Director 23 May 2022, 16:18
/report/000120919122031177-swain-judith-l-2022-05-19 Prometheus Biosciences, Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 19:28
LXRX LEXICON PHARMACEUTICALS, INC. 30 Apr 2022 2 $0 4 Director 02 May 2022, 16:22
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .